References

10.1093/ajhp/zxaa036

10.1093/ajhp/zxaa036 · 2020 · External reference

Clinical decision support for precision dosing: opportunities for enhanced equity and inclusion in health care

10.1002/cpt.2799 · 2023 · External reference

Comparing two-sample log-linear exposure estimation with Bayesian model-informed precision dosing of tobramycin in adult patients with cystic fibrosis

10.1128/aac.01040-24 · 2025 · External reference

External validation of population pharmacokinetic models for meropenem in critically ill adult patients

10.1016/j.jgar.2025.05.015 · 2025 · External reference

Impacts of age and BMI on vancomycin model choice in a Bayesian software: lessons from a very large multi-site retrospective study

10.1002/phar.4613 · 2024 · External reference

Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study

10.1093/jpp/rgaf038 · 2025 · External reference

Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations

10.1093/jac/dkp085 · 2009 · External reference

Hospitalized patients with and without hemodialysis have markedly different vancomycin pharmacokinetics: a population pharmacokinetic model-based analysis

10.1097/ftd.0000000000000490 · 2018 · External reference

Absorption to excretion: the aging Body’s take on drugs – a review of pharmacokinetic changes and their impact on medication management

10.1007/s40495-025-00425-y · 2025 · External reference

Prediction of creatinine clearance from serum creatinine

10.1159/000180580 · 1976 · External reference

New creatinine- and cystatin C–based equations to estimate GFR without race

10.1056/nejmoa2102953 · 2021 · External reference

Use of age-adjusted serum creatinine in a vancomycin pharmacokinetic model decreases predictive performance in elderly patients

10.1097/ftd.0000000000000819 · 2021 · External reference

Comparing actual and rounded serum creatinine concentration for assessing the accuracy of vancomycin dosing in elderly patients: a single-center retrospective study

10.3390/healthcare12111144 · 2024 · External reference

Vancomycin and gentamicin pharmacokinetic alterations in an adolescent amputee

2013 · External reference

Pharmacokinetic considerations in amputees

10.1177/0897190020942659 · 2021 · External reference

Monitoring of renal function in patients with spinal cord injury

10.1046/j.1464-410x.2000.00680.x · 2000 · External reference

Injection drug use and right sided endocarditis

10.1136/heart.89.5.577 · 2003 · External reference

Pilot study of a Bayesian approach to estimate vancomycin exposure in obese patients with limited pharmacokinetic sampling

10.1128/aac.02478-16 · 2017 · External reference

Vancomycin pharmacokinetics throughout life: results from a pooled population analysis and evaluation of current dosing recommendations

10.1007/s40262-018-0727-5 · 2019 · External reference

2024 ASHP midyear clinical meeting poster abstracts

2025 · External reference

Quantification of lean bodyweight

10.2165/00003088-200544100-00004 · 2005 · External reference

Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients [e-pub ahead of print]

2025 · External reference

Vancomycin: an analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population

10.1002/phar.2941 · 2024 · External reference

Kidney function estimation equations: a narrative review

10.1007/s11845-025-03874-y · 2025 · External reference

Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis

10.1002/hep.26556 · 2014 · External reference

CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations

10.1186/s12882-017-0637-z · 2017 · External reference